These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30650068)

  • 1. Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver.
    Tanoue Y; Nanashima A; Yano K; Fujii Y; Hiyoshi M; Imamura N; Hamada T; Ikenoue M; Wada T; Mizutani Y; Hirai T
    Nucl Med Commun; 2019 Feb; 40(2):145-152. PubMed ID: 30650068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin is correlated with liver functional parameters, but did not predict postoperative morbidity.
    Yano K; Nanashima A; Fujii Y; Hiyoshi M; Imamura N; Hamada T; Tsuchimochi Y; Wada T; Mizutani Y; Hirai T
    Nucl Med Commun; 2017 Aug; 38(8):701-707. PubMed ID: 28644197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictability of
    Kato A; Nakamoto Y; Ishimori T; Seo S; Uemoto S; Togashi K
    AJR Am J Roentgenol; 2018 Jan; 210(1):158-165. PubMed ID: 29023153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative maximal removal rate of technetium-99m-galactosyl-human serum albumin of the remnant liver is associated with postoperative tumor relapse in hepatitis C virus-related hepatocellular carcinoma.
    Yano K; Kondo K; Nanashima A; Fujii Y; Imamura N; Hiyoshi M; Hamada T; Tsuchimochi Y; Wada T; Mizutani Y; Hirai T
    Nucl Med Commun; 2018 Jan; 39(1):28-34. PubMed ID: 29099413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation set analysis to predict postoperative outcomes by technetium-99m galactosyl serum albumin scintigraphy for hepatectomy.
    Nanashima A; Hiyoshi M; Imamura N; Yano K; Hamada T; Wada T; Nishimuta M; Shimizu I; Mizutani Y
    Nucl Med Commun; 2020 Apr; 41(4):320-326. PubMed ID: 32073550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of hepatic functional parameters with changes of functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization: a follow-up report.
    Nanashima A; Tobinaga S; Abo T; Sumida Y; Araki M; Hayashi H; Sakamoto I; Kudo T; Takeshita H; Hidaka S; Sawai T; Hatano K; Nagayasu T
    J Surg Res; 2010 Dec; 164(2):e235-42. PubMed ID: 20869076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of examining hepatic functional volume using technetium-99m galactosyl serum albumin scintigraphy in hepatocellular carcinoma.
    Nanashima A; Abo T; Kudo T; Sakamoto I; Hayashi H; Murakami G; Takeshita H; Hidaka S; Kido Y; Nagayasu T
    Nucl Med Commun; 2013 May; 34(5):478-88. PubMed ID: 23458853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography.
    Mitsumori A; Nagaya I; Kimoto S; Akaki S; Togami I; Takeda Y; Joja I; Hiraki Y
    Eur J Nucl Med; 1998 Oct; 25(10):1377-82. PubMed ID: 9818276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsuperiority of technetium-99m-galactosyl human serum albumin scintigraphy over conventional volumetry for assessing the future liver remnant in patients undergoing hepatectomy after portal vein embolization.
    Yao S; Taura K; Yoh T; Nishio T; Koyama Y; Ogiso S; Okamoto T; Fukumitsu K; Ishii T; Seo S; Hata K; Masui T; Shimizu H; Ishimori T; Hatano E
    Surgery; 2023 Feb; 173(2):435-441. PubMed ID: 36372575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve.
    Fujioka H; Kawashita Y; Kamohara Y; Yamashita A; Mizoe A; Yamaguchi J; Azuma T; Furui J; Kanematsu T
    J Clin Gastroenterol; 1999 Jun; 28(4):329-33. PubMed ID: 10372930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural course of the remnant hepatic functional reserve as estimated by technetium-99m-galactosyl human serum albumin scintigraphy after a hepatectomy.
    Shimizu Y; Aoki T; Kusano T; Matsuda K; Enami Y; Yasuda D; Koizumi T; Niiya T; Murai N; Kato H; Kusano M; Murakami M
    J Gastroenterol; 2010 Mar; 45(3):308-16. PubMed ID: 19894018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rank classification based on the combination of indocyanine green retention rate at 15 min and (99m)Tc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection.
    Okabe H; Beppu T; Hayashi H; Mima K; Nakagawa S; Kuroki H; Imai K; Nitta H; Masuda T; Hashimoto D; Chikamoto A; Watanabe M; Ishiko T; Yoshida M; Yamashita Y; Baba H
    Nucl Med Commun; 2014 May; 35(5):478-83. PubMed ID: 24686196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional liver reserve parameters predictive for posthepatectomy complications.
    Nanashima A; Abo T; Arai J; Matsumoto H; Kudo T; Nagayasu T
    J Surg Res; 2013 Nov; 185(1):127-35. PubMed ID: 23746962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection.
    Kwon AH; Matsui Y; Kaibori M; Ha-Kawa SK
    Surgery; 2006 Sep; 140(3):379-86. PubMed ID: 16934599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy.
    Iguchi T; Sato S; Kouno Y; Okumura Y; Akaki S; Tsuda T; Kobayashi K; Kanazawa S; Hiraki Y
    Ann Nucl Med; 2003 May; 17(3):227-33. PubMed ID: 12846545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function assessment using 99mTc-GSA single-photon emission computed tomography (SPECT)/CT fusion imaging in hilar bile duct cancer: A retrospective study.
    Sumiyoshi T; Shima Y; Okabayashi T; Kozuki A; Hata Y; Noda Y; Kouno M; Miyagawa K; Tokorodani R; Saisaka Y; Tokumaru T; Nakamura T; Morita S
    Surgery; 2016 Jul; 160(1):118-126. PubMed ID: 27059635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function.
    Nanashima A; Tobinaga S; Abo T; Nonaka T; Takeshita H; Hidaka S; Sawai T; Nagayasu T
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):871-8. PubMed ID: 20734210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
    Nakamura I; Iimuro Y; Hai S; Kondo Y; Hatano E; Fujimoto J
    Eur Surg Res; 2018; 59(1-2):12-22. PubMed ID: 29332090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy.
    Kwon AH; Ha-Kawa SK; Uetsuji S; Kamiyama Y; Tanaka Y
    Surgery; 1995 Apr; 117(4):429-34. PubMed ID: 7716725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and Internal Validation of a Prognostic Score for Post-hepatectomy Liver Failure Based on Functional Liver Parameters Estimated via TC-99m GSA.
    Kasai M; Ha-Kawa S; Aihara T; Ikuta S; Nakajima T; Yamanaka N
    Cureus; 2023 Jul; 15(7):e42297. PubMed ID: 37609100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.